Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-18

FDA Approved: APRACLONIDINE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for apraclonidine from Sandoz Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apraclonidine (Apraclonidine)

Snippet

SUPPL AP for APRACLONIDINE (APRACLONIDINE)